Human Milk Oligosaccharides (HMO) Market to Witness Massive Growth (2024-2031)| Elicityl SA, Medolac Laboratories, Inbiose NV, Glycosyn, ZuChem

DataM Intelligence has released a new research report on the Human Milk Oligosaccharides (HMO) market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits, gross margins, and strategic decisions in the global market. The report is enriched with tables, charts, and infographics for a clear presentation of the findings.

The Global Human Milk Oligosaccharides (HMO) Market was valued at USD 196.5 million in 2022 and is projected to witness lucrative growth by reaching up to USD 850.5 million by 2031.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/human-milk-oligosaccharides-market

Human Milk Oligosaccharides (HMO) are complex carbohydrates found in human breast milk that serve as a vital source of nutrition for infants. HMOs are the third most abundant solid component in human milk, after lactose and lipids. They play crucial roles in promoting gut health, enhancing immune function, and supporting the development of beneficial gut microbiota in infants. By preventing pathogen adhesion, HMOs contribute to the protection against infections and inflammation. Additionally, they are believed to have prebiotic effects, helping to foster a healthy intestinal environment and improving nutrient absorption. Due to their unique properties, HMOs are increasingly being studied for potential applications in infant formula and functional foods.

List of the Key Players in the Human Milk Oligosaccharides (HMO) Market:

Elicityl SA, Medolac Laboratories, Inbiose NV, Glycosyn, ZuChem, Jennewein Biotechnologie GmbH, Glycom A/S, Dextra Laboratories Limited, DuPont Nutrition & Health, and Nestlé Health Science.

Key Developments:

In November 2022, Kyowa Hakko Bio Co. Ltd, a subsidiary of Kirin Holdings Company, announced the establishment of a human milk oligosaccharide (HMO) production facility at its affiliate, Thai Kyowa Biotechnologies Co., Ltd., in Thailand.

In October 2022, FrieslandCampina received regulatory approval from authorities in Australia and New Zealand for its trademarked 2'-fucosyllactose product, Aequival, for use in infant milk formula.

In April 2020, Royal DSM, a global leader in Nutrition, Health, and Sustainable Living, completed the acquisition of Glycom, a key supplier of Human Milk Oligosaccharides (HMO), for an enterprise value of €765 million.

Research Process:

Both primary and secondary data sources have been used in the global Human Milk Oligosaccharides (HMO) Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Human Milk Oligosaccharides (HMO) Market:

By Product: Lacto-N-neotetraose (LNnT), Lacto-N-tetraose (LNT), 2'-Fucosyllactose (2'FL), 3'-Fucosyllactose (3'FL), 3'-Sialyllactose (3'SL), 6'-Sialyllactose (6'SL), Others

By Type: Neutral, Acidic, Others

By Application: Infant Formula, Dietary Supplements, Functional Food and Beverages, Others

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/human-milk-oligosaccharides-market

Regional Analysis:

➣ North America (US, Canada, Mexico)

➣ Europe (Germany, Russia, UK, France, Italy, Spain, Rest of Europe)

➣ Asia-Pacific (China, India, Japan, Australia, Rest of Asia Pacific)

➣ South America (Brazil, Argentina, Rest of South America)

➣ Middle East and Africa

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Human Milk Oligosaccharides (HMO) market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Human Milk Oligosaccharides (HMO) Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Human Milk Oligosaccharides (HMO) market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Human Milk Oligosaccharides (HMO) Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/human-milk-oligosaccharides-market

The Research Report Offers Answers To The Following Questions:

☛ What is the expected growth rate of the global market for the forecast period?

☛ What are the key driving factors that are responsible to shape the fate of the Human Milk Oligosaccharides (HMO) market during the forecast period?

☛ What will be the overall size of the market during the analysis period?

☛ What are the prominent market trends which influence the development of the Human Milk Oligosaccharides (HMO) market across various regions?

☛ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☛ What are the challenges and threats that are likely to act as a barrier to the growth of the Human Milk Oligosaccharides (HMO) market?

☛ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.